OAM
INSP icon

Oppenheimer Asset Management’s Inspire Medical Systems INSP Stock Holding History

Oppenheimer Asset Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,161
Closed -$1.97M – 1191
2025
Q2 		$1.97M Sell
15,161
-45
-0.3% -$6.53K 0.02% 558
2025
Q1 		$2.42M Buy
15,206
+2,179
+17% +$394K 0.03% 471
2024
Q4 		$2.41M Buy
13,027
+2,375
+22% +$461K 0.03% 485
2024
Q3 		$2.25M Sell
10,652
-116
-1% -$20.2K 0.03% 503
2024
Q2 		$1.44M Buy
10,768
+2,242
+26% +$424K 0.02% 626
2024
Q1 		$1.83M Sell
8,526
-459
-5% -$90K 0.03% 516
2023
Q4 		$1.83M Buy
8,985
+868
+11% +$141K 0.03% 540
2023
Q3 		$1.61M Buy
8,117
+5,621
+225% +$1.42M 0.02% 558
2023
Q2 		$810K Buy
2,496
+277
+12% +$79.1K 0.01% 748
2023
Q1 		$519K Buy
2,219
+623
+39% +$157K 0.01% 845
2022
Q4 		$402K Sell
1,596
-329
-17% -$70.1K 0.01% 906
2022
Q3 		$341K Sell
1,925
-31
-2% -$6.23K 0.01% 923
2022
Q2 		$357K Sell
1,956
-573
-23% -$114K 0.01% 940
2022
Q1 		$649K Sell
2,529
-143
-5% -$32.7K 0.01% 857
2021
Q4 		$615K Sell
2,672
-15
-0.6% -$3.66K 0.01% 908
2021
Q3 		$625K Buy
2,687
+107
+4% +$22.3K 0.01% 877
2021
Q2 		$499K Buy
2,580
+1,079
+72% +$214K 0.01% 960
2021
Q1 		$311K Buy
+1,501
New +$319K ﹤0.01% 1023
2020
Q2 		– Sell
-302
Closed -$18K – 1250
2020
Q1 		$18K Sell
302
-6
-2% -$444 ﹤0.01% 1390
2019
Q4 		$23K Buy
+308
New +$19.8K ﹤0.01% 1438

Other funds holding INSP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Oppenheimer Asset Management's INSP Position: Q3 2025 in Review

Oppenheimer Asset Management sold out of Inspire Medical Systems (INSP) in Q3 2025, closing a stake of 15,161 shares — an estimated $1.97M sold.

Oppenheimer Asset Management first reported a position in INSP in Q4 2019 and held it in 20 quarters. The position peaked at $2.42M in Q1 2025. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

  • Oppenheimer Asset Management reported no remaining Inspire Medical Systems position as of Q3 2025 after selling out during the quarter.
  • Oppenheimer Asset Management sold 15,161 Inspire Medical Systems shares in Q3 2025, an estimated $1.97M.
  • Oppenheimer Asset Management first reported a position in Inspire Medical Systems in Q4 2019 and held it in 20 quarters.
  • Oppenheimer Asset Management's Inspire Medical Systems position peaked at $2.42M in Q1 2025.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on Oppenheimer Asset Management's 13F filing for Q3 2025, filed 6 Nov 2025.